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OBJECTIVES: The gut microbiota is associated with obesity and weight loss after bariatric surgery and has been
related to its changing pattern. Exactly how the bacterial population affects weight loss and the results of
surgery remain controversial. This study aimed to evaluate the intestinal microbiota of superobese patients
before and after gastric bypass surgery (RYGB).
METHOD: DNA fragments for the microbiota obtained from stool samples collected from nine superobese
patients before and after bariatric surgery were sequenced using Ion Torrent.
RESULTS: We observed that with a mean follow-up of 15 months, patients achieved 55.9% excess weight
loss (EWL). A significant population reduction in the Proteobacteria phylum (11 to 2%, p=0.0025) was observed
after surgery, while no difference was seen in Firmicutes and Bacteroidetes. Further analyses performed
with two specific individuals with divergent clinical outcomes showed a change in the pattern between them,
with a significant increase in Firmicutes and a decrease in Bacteroidetes in the patient with less weight loss
(%EWL 50.79 vs. 61.85).
CONCLUSIONS: RYGB affects the microbiota of superobese patients, with a significant reduction in
Proteobacteria in patients with different weight loss, showing that different bacteria may contribute to
the process.
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’ INTRODUCTION
Obesity is a chronic disease that affects more than
600 million people worldwide (1). The pathophysiology is
considered multifactorial, with the gut microbiota influencing
the energy balance, the inflammatory state, the intestinal
barrier and the regulation of food intake, leading to an increase
in body weight (2).
An experimental study showed a higher proportion of
the Firmicutes phylum in genetically obese mice than in
eutrophic controls, with a change in the ratio of Firmicutes/
Bacteroidetes after weight loss (3). In humans, a lower
proportion of Bacteroidetes has also been observed in obese
patients than eutrophic controls, in addition to changes in the
amount of Actinobacteria (4). A higher proportion of Firmi-
cutes is associated with greater energy absorption, while more
Bacteroidetes is associated with a decrease (5). Nevertheless,
the participation of genera and species also seems important
since the distribution of phyla between lean and obese
individuals shows no difference in some studies (6).
Bariatric surgery is considered the gold standard treatment
for morbid obesity. Despite the rise of sleeve gastrectomy,
Roux-en-Y Gastric Bypass (RYGB) is still the most accom-
plished weight loss procedure in Brazil (7). Patients sub-
mitted to this technique 3 to 12 months postoperatively
present a reduction in Firmicutes and Bacteroidetes and an
increase in Gammaproteobacteria (8). Considering genera and
species, an increase in E. coli and reduction in Bifidobacteria and
Lactobacillus has been observed (9). However, there is an
uncertain significance of these findings, and recent con-
flicting data show an increase in Firmicutes and reduc-
tion in Bacteroidetes in some individuals, which is associated
with variations in diabetes control in the postoperative period
(10).
The influence of factors such as diet, environment and
medication use is certain in long-term follow-up after
bariatric surgery (11), but it is not known how the intestinalDOI: 10.6061/clinics/2019/e1198
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microbiota influences this process. Satisfactory sustained
weight loss is commonly achieved after bariatric surgery,
with 65% excess weight loss (%EWL) after RYGB (12).
Nevertheless, weight regain and recurrence of obesity is a
major concern in long-term follow-up, with multifactorial
causes (13,14). It is estimated that up to 20% of patients will
present with treatment failure, particularly among super-
obese patients (BMI above 50 kg/m2) (15).
Consequently, in this study, we evaluated the intestinal
microbiota of superobese patients before and after the RYGB
technique.
’ MATERIALS AND METHODS
Ethics approval and consent to participate: All procedures
involving human subjects were approved by the Internal
Review Board of the University of São Paulo (‘‘Comissão de
Ética para Análise de Projetos de Pesquisa’’ - CAPPesq
number 399.864, 09/19/2013). Participants provided written
consent, which was securely stored in our laboratory,
according to Brazilian research policy.
Study population
The study enrolled nine superobese patients submitted to
bariatric surgery from 2014 to 2015 at Hospital das Clínicas,
University of São Paulo, Medical School, at São Paulo, Brazil.
Inclusion criteria were BMIX50 kg/m2, and exclusion
criteria were the use of antibiotics or acute diarrhea three
months prior to surgery, chronic diarrhea, inflammatory
bowel disease and previous gastrointestinal surgery (includ-
ing revisional bariatric surgery).
Fecal samples for microbiota study were collected before
and 12 to 24 months after surgery. The surgical technique
was RYGB with both alimentary and biliopancreatic limbs of
100 cm each. Postoperative follow-up examinations were
performed routinely at 1, 3, 6, 12, 18 and 24 months. This
study was approved by the ethics committee (CAPPesq
number 399.864).
Collection and storage of stool samples
A Fisher Fecal Commode Collection Kit was used to collect
the stool samples, and they were placed at -80oC up to 1 hour
after collection and maintained there until DNA extraction.
DNA extraction
Fecal DNA extraction was performed using a Power
Soil DNA Isolation Kits (Mobio Laboratories, Carlsbad, CA),
with modifications (16). Briefly, the sample tubes were
heated for 10 minutes at 65oC and a further 10 minutes at
95oC and then centrifuged for 2 minutes after the addition of
C3 solution. All other steps were performed according to the
manufacturer’s instructions.
Library preparation and 16S sequencing
The V4 variable region of the 16S rRNA gene was ampli-
fied using the primers 515F (50-GTGCCAGCMGCCGCGG
TAA-30) and 806R (50-GGACTACHVGGGTWTCTAAT-30)
(17). These primers were designed to include the adaptor
sequences used in the Ion Torrent sequencing library pre-
paration protocol, containing the barcode sequence on the
forward primer. Samples were normalized to 12.5 ng/ml DNA
material per library, and the amplification was performed
using a Veriti 96 well PCR (Applied Biosystems) followed
by AMPure XP bead cleanup (Beckman Coulter). The PCR
conditions used were 94oC for 3 minutes, followed by
40 cycles of denaturation at 94oC for 30 seconds, annealing
at 58oC for 30 seconds and extension at 68oC for 1 minute.
PCR products were analyzed by 1.5% agarose gel electro-
phoresis. PCR emulsion was carried out using an Ion
PGMt Template OT2 400 Kit in accordance with the man-
ufacturer ’s instructions. Sequencing was carried using an
Ion 318TM chip kit v2, with 16 libraries per chip, using an Ion
PGMt Sequencing 400 Kit, on an Ion TorrentTM Personal
Genome Machine (ThermoFisher, USA). All the samples were
sequenced once.
Data analysis
The obtained sequences were processed using the Ion
Torrent server v5.0.4. Low quality and polyclonal sequences
were excluded by filtering. Reads maintained were grouped
into operational taxonomic units (OTUs) based on 97%
identity using UCLUST UPARSE v7 (18). The representative
sequences were then classified by taxonomy using the
Greengenes database v13.8 (19) as a reference on the QIIME
(Quantitative Insights Into Microbial Ecology) software
package v1.8 (20).
Statistical analysis
The species richness/diversity were assessed by pairwise
comparisons for alpha diversity by OTUs, Shannon diversity
index, Chao1 richness estimate, and Simpson diversity index.
To determine the effect of surgery on the shared diversity
between samples, beta diversity ratings were calculated based
on weighted and unweighted UniFrac distance matrices,
comparing samples pre- and post-bariatric surgery.
To determine differences in the microbiota before and after
bariatric surgery, the nonparametric Kruskal-Wallis test was
applied. To compare the percentage of bacteria present
before and after the surgery in two patients, the Chi-squared
test was used. All analyses were performed using GraphPad
Prism 6TM statistical software. A p-value of o0.05 after
Bonferroni correction was considered statistically significant.
’ RESULTS
The clinical and epidemiological data from the patients
included in the study are presented in Table 1. Most patients
were female and Caucasian, with a mean age of 41.9 years
and a preoperative BMI of 56.47 kg/m2. In a mean follow-up
of 15 months, they achieved an EWL of 55.9%.
The analyses were performed by grouping all patient data
before and after surgery. The samples were grouped with
greater proximity related to the surgical status and compared
by the diversity analysis of the samples via the UniFrac
method (Figure 1).
A significant reduction in the Proteobacteria phylum
(11% to 2%, p=0.0025) was observed after surgery, but no
Table 1 - Demographic and weight data from the patients
submitted to bariatric surgery.
N=9
Female gender, n (%) 6 (66.7%)
Age, years (min-max) 41.9 (16 – 59)
Caucasian ethnicity, n (%) 8 (88.8%)
Preoperative BMI, kg/m2 56.47 (50.69 – 62.87)
Postoperative BMI, kg/m2 38.74 (36.73 – 39.75)
%EWL 55.89 (50.79 – 61.85)
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significant difference was seen in Firmicutes and Bacter-
oidetes. Differences at the family level for Rikenellaceae,
Enterobacteriaceae, Sucinivibroniaceae and Odoribacteria-
ceae and at the genus level for Roseburia were not maintained
after Bonferroni correction (Figure 2).
Further analyses were performed with two individuals,
comparing the data before and after surgery. These patients
showed opposite results of weight loss. Patient A had a 61.85%
EWL, and patient B had a 50.79% EWL. Considering the
bacterial abundance at the phylum level, the abundance of
Bacteroidetes and Firmicutes was different pre- and post-
operatively. Bacteroidetes was significantly reduced in patient B
after surgery (86 to 42%, po0.0001). Conversely, Firmicutes was
diminished in patient A (61 to 42%, p=0.0107) and increased in
patient B (13 to 35%, p=0.0004). At the class level, Bacteroidia
and Clostridia showed trends similar to those of their phyla,
Bacteroidetes and Firmicutes, respectively. The Clostridia class
was significantly reduced after surgery in patient A (59% to
34%, p=0.0006) and increased in patient B (11% to 33%,
p=0.0006). At the family level, Bacteroidaceae and Lachnospir-
aceae maintained trends similar to those of their corresponding
class and phyla, Bacteroidia/Bacteroidetes and Clostridia/Firmi-
cutes, respectively. Furthermore, Bacteroidaceae was significantly
reduced in patient B (85% to 31%, po0.0001), and Lachnospir-
aceae was reduced in patient A (36% to 15%, p=0.0011) and
increased in patient B (6% to 18%, p=0.0153) (Figure 3).
Figure 1 - PCoA analysis based on UniFrac distance matrices comparing the abundance of intestinal bacteria before and after surgery.
A: unweighted; B: weighted.
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’ DISCUSSION
This longitudinal study utilizing high-throughput Ion
Torrent sequencing in superobese patients before and after
bariatric surgery showed a statistically significant reduction
in the Proteobacteria phylum after surgery and no signifi-
cant changes in Firmicutes and Bacteroidetes. These findings
are in contrast with recent studies relating Proteobacteria to
inflammation, dysbiosis and extraintestinal diseases (21).
Changes in the microbiota following bariatric surgery are
related to surgical technique, and a meta-analysis of six
studies demonstrated that RYGB caused an increase in
Proteobacteria and a decrease in Firmicutes (22). Conflicting
data regarding the Firmicutes and Bacteroides phyla are
related to obesity and bariatric surgery (3). These converse
findings are often related to the diet (23,24) and changes
in acid exposure due to surgical technique and routine use
of proton pump inhibitor (PPI) drugs (8,9). In our study,
no patient used long-term PPI treatment.
Two patients with divergent weight loss outcomes indi-
vidually analyzed showed inverse alterations of Firmicutes,
Clostridia and Lachnospiraceae. Additionally, the patient
with the worst weight loss (%EWL of 50.79%) had a sig-
nificant decrease in Bacteroidetes and increase in Firmi-
cutes. Although this similar order is seen in obese patients
in clinical studies, the differences at the phylum level
between lean and obese individuals have shown conflicting
outcomes (5,6).
Figure 2 - Continued.
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Figure 2 - Relative abundance at the phyla, class, family and genus levels of fecal samples, comparing patients before and after surgery.
A – Phyla; B – Class; C – Family; D – Genus.
5
CLINICS 2019;74:e1198 Microbiome in superobese after surgery
Pajecki D et al.
Some limitations in our study were observed, mostly
related to the small sample size. Likewise, our findings could
be affected by uncontrolled factors, such as postoperative
diet. The surgical technique chosen can also affect the study
outcome, but RYGB is the most frequent technique in
microbiota studies (22).
The bacterial region and the methods used to detect them
are very important to assessing the microbiota, and they can
influence the results. The V4 region of the 16S bacterial RNA
gene, which contains both conserved and variable regions,
is commonly sequenced to identify bacterial species
and was used in this study. Prior studies present different
methods ranging from simple amplification of the 16S
RNA gene by PCR to next-generation sequencing. Semicon-
ductor sequencing was used in the present study. This
methodology has limitations, such as pairing errors and
homopolymer limited detection, which must be taken into
account, according to the type of study (25). Different
approaches have been used in the Ion Torrent platform
analyses to minimize these errors (26). Even using the same
data, the methodology chosen for analysis may result in
different findings (27).
To what extent the changes in the microbiota of
this group of patients may influence weight loss or regain
is still uncertain. Further knowledge of these modifica-
tions, with the identification of species that may have a
more positive effect in this process, could contribute to the
development of microbiota modulation therapies with
prebiotics, probiotics or even fecal transplantation in
operated patients.
Figure 3 - Continued.
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Our findings support previous literature outcomes of
changes in the microbiota after surgery, with a significant
reduction in Proteobacteria associated with mostly inflam-
mation and extraintestinal diseases. Additionally, when
comparing data from patients with different clinical outcomes,
we observed that Firmicutes and Bacteroidetes may not be
responsible for the observed phenotype, and other bacteria,
even in lower proportions, may not be disregarded.
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